Apremilast Treatment for Pruritus and Quality of Life in Scalp Psoriasis
Status:
Unknown status
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
A phase 4 multicenter, randomized, placebo-controlled Study evaluating the Effect of
Apremilast on Pruritus and Quality of Life of Patients with moderate-to-severe Scalp
Psoriasis